Compare Medtronic PLC (MDT) vs Thomson Reuters Corp (TRI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs Thomson Reuters Corp — how do they compare? Medtronic PLC trades at $88.79 (market cap $112.24B), while Thomson Reuters Corp trades at $103.08 (market cap $43.89B). The key difference: Medtronic PLC is far larger — about 2.6× Thomson Reuters Corp's market cap, and Medtronic PLC pays the higher dividend (3.28%). Which is the better fit depends on your goals — on Pluang, investors hold Medtronic PLC for 63 Days and Thomson Reuters Corp for 63 Days on average.
| MDT | TRI | |
|---|---|---|
Market Cap | $112.24B | $43.89B |
Volume | 105,663,236 | 1,648,199 |
Sector | Health | Industrials |
52-Week High | $105.35 | $163.45 |
52-Week Low | $73.75 | $76.55 |
Typical Hold Time | 63 Days | 63 Days |
Enterprise Value | $131.58B | $46.51B |
Dividend Yield | 3.28% | 2.58% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $88.48, up 3.47% today, with a bullish analyst consensus and a $97.80 price target. The stock shows strong fundamentals with revenue growth to $33.54B in 2025 and a net income margin of 13.93%. Recent earnings beats and a 49-year dividend growth streak highlight operational strength, though technical indicators signal a near-term bearish trend with key support at $87.
MDT presents a compelling long-term investment with stable profitability and dividend reliability, but faces risks from debt increases and competitive pressures. Upside potential exists if the company maintains earnings momentum and executes on growth initiatives, while volatility may persist due to market sentiment shifts.
Thomson Reuters (TRI) trades at $103.21, up 3.96% today, showing strong momentum near resistance at $103. The stock maintains robust fundamentals with 10% organic growth in core businesses and a 21.22% net income margin. Recent strategic moves include divesting the printing unit to focus on technology and launching a proprietary AI model, positioning for future growth. Technical indicators show bullish momentum with the current price approaching key resistance levels.
The outlook remains positive with analyst consensus targeting $133.25 (29% upside), supported by recurring revenue strength and AI expansion. Risks include cybersecurity incidents and execution challenges in tech transformation. With 52% of analysts rating Buy and strong institutional interest, TRI presents a growth opportunity tempered by valuation concerns at current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About Thomson Reuters Corp
Thomson Reuters is the result of the $17.6 billion megamerger of Canada's Thomson and the United Kingdom's Reuters Group in 2008 and the 2018 carve-out of its finance and risk business, Refinitiv, in which it holds a 45% stake. In 2019, the company agreed to exchange its 45% stake in Refinitiv for a 15% stake in LSE, which closed in early 2021. Since the divestiture, the company is more concentrated on selling its flagship legal data and software, Westlaw, and its tax accounting software, Onesource. Reuters sees roughly 80% of revenue and 70% of expenses attributed to the United States, while the remainder (largely through the global print and Reuters News segments) is distributed across Latin America, Europe, the Middle East, Africa, and Asia-Pacific.
Read more on TRI →
